cgp 54626 has been researched along with muscimol in 1 studies
| Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (muscimol) | Trials (muscimol) | Recent Studies (post-2010) (muscimol) |
|---|---|---|---|---|---|
| 57 | 0 | 16 | 4,699 | 9 | 887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson, SC; McFarlane, S | 1 |
1 other study(ies) available for cgp 54626 and muscimol
| Article | Year |
|---|---|
GABA and development of the Xenopus optic projection.
Topics: Analysis of Variance; Animals; Baclofen; Blotting, Western; Culture Techniques; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Embryonic Development; Epithelial Cells; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Immunohistochemistry; Muscimol; Neurites; Neurons; Organophosphorus Compounds; Receptors, GABA; Receptors, GABA-A; Receptors, GABA-B; Retinal Ganglion Cells; Visual Pathways; Xenopus laevis | 2002 |